What the evidence does not support Large-scale human clinical trials confirming safety and efficacy have not been published
DSIP subsequently became the focus of numerous experimental studies examining peptide structure-function relationships and signalling dynamics within controlled laboratory settings
When these defences fail, radical-induced lipid oxidation can damage DNA, proteins, and lipids, processes now thought to contribute directly to asthma pathogenesis
That growth hormone then increases levels of insulin-like growth factor 1 (IGF-1), which sets off a cascade of metabolic effects
Its main effects include: Increasing lipolysis (fat breakdown) Reducing lipogenesis (fat storage) Improving fat metabolism signaling Doing so without affecting muscle, bone, or glucose regulation Importantly: It does not stimulate growth hormone release It does not rely on pituitary feedback loops It does not act on central appetite pathways This is why it has such a clean safety profile
Tier 4: General Health Safety Panel These won't tell you if BPC-157 is "working," but they make sure it's not causing problems